In the world of cancer research and innovation, collaboration and communication are the cornerstones of progress. With this philosophy at the forefront, the VCCC Alliance and MPCCC hosted the Precision Oncology Summit this year, where over 200 leading experts in cancer genomics met in Melbourne to discuss advancing patient access [...]
The Monash Partners Comprehensive Cancer Consortium (MPCCC) has embarked on a roadshow series to continue to improve connectivity and collaboration with our partner hospitals, fostering face-to-face interactions and deepening our bonds with the oncology and pathology community. The roadshows have been a platform for meaningful dialogue and exchange, creating opportunities [...]
The MPCCC was delighted to host a visit from the Victorian Parliamentary Secretary for Mental Health & Suicide Prevention and Health Infrastructure, Mr Tim Richardson MP, to Monash Partners Comprehensive Cancer Consortium (MPCCC) at Monash University on Thursday, June 1. Welcomed by Co-Directors, Prof Mark Shackleton and Prof Melissa [...]
MPCCC and Omico have signed an MOU that saw MPCCC become a member site in Omico national clinical trial network (ONCTN). This MOU sets out a framework for Omico and MPCCC to work collaboratively to maximise patient access to a greater range of clinical trials through the co-ordinated distribution of [...]
More than 200 experts in cancer genomics gathered in Melbourne last week to discuss how we can improve access to precision oncology for patients. The event, coordinated by the VCCC Alliance and Monash Comprehensive Cancer Consortium (MPCCC), featured a range of speakers from both Victoria and abroad, including Professor Olivier [...]
Melbourne researchers have discovered how a rogue protein produces ‘Dr Jekyll and Mr Hyde’ cancer cells, which could lead to improved treatments for melanoma and other cancers. The world-first Monash University-led study, published in the journal Oncogene, focused on a protein called EZH2, which is known to promote the development and [...]
Women are still facing barriers accessing certain cancer treatments and testing in some parts of Victoria. Last week, Monash Partners Comprehensive Cancer Consortium (MPCCC) together with Monash Biomedicine Discovery Institute (BDI) brought together a powerhouse panel to discuss equity issues this International Women’s Day. The panel discussion, titled "Women's Health [...]
We are proud to be kicking off 2023 with a bang, by announcing the launch of our new logo, and refreshed colours, as part of the ongoing growth and transformation of our consortium. Just over this past 12 months we have seen significant changes such as; Appointed our Co-Directors, Prof [...]
It’s been a complex year. As I write, the community is preparing for a festive season free of the restrictions we have had to navigate in recent years, yet these freedoms are associated with a fourth COVID-19 wave, continuing pressures in our hospitals and healthcare systems, workforce shortages and ongoing [...]
A new study led by Monash Health and Monash University researchers has uncovered important insights to explain COVID19 vaccine hesitancy amongst people with solid cancers, and recommended practical solutions to better inform and support patients. Dr Nathan Bain and Dr Mike Nguyen co-led a recently published paper in online journal, [...]
